DJIA 17,042.90 -28.32 -0.17%
NASDAQ 4,493.39 -12.46 -0.28%
S&P 500 1,972.29 -5.51 -0.28%
market minute promo

53.75 0.19 (0.35%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

TEVA $53.75 0.35%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $53.77
Previous Close $53.56
Daily Range $53.46 - $54.25
52-Week Range $36.26 - $55.70
Market Cap $45.9B
P/E Ratio 35.95
Dividend (Yield) $1.20 (2.2%)
Ex-Dividend Date
Dividend Pay Date
08/19/14
09/04/14
Volume 4,320,104
Average Daily Volume 3,353,768
Current FY EPS $4.94

Sector

Healthcare

Industry

Drugs

Teva Pharmaceutical Industries (TEVA) Description

A global pharmaceutical company, Teva develops, produces, and markets generic drugs covering all major treatment categories. Website: http://www.tevapharm.com/

News & Commentary Rss Feed

High Blood Pressure Is Most Prevalent in These 5 States

High blood pressure affects 67 million Americans and is a direct or contributing factor to roughly 1,000 deaths per day in the U.S. Find out what's being done to help combat this disease.

Overpriced Expectations: Alcobra Will Get To Second Base, But No Home Run. Options Are Mispriced For

Overpriced Expectations: Alcobra Will Get To Second Base, But No Home Run. Options Are Mispriced For An Unlikely Event

5 Best Stocks to Buy for Q4 and Beyond

Comparative Analysis Reveals Undervalued Asset In Antares' Pipeline: First And Only Testosterone Aut

Comparative Analysis Reveals Undervalued Asset In Antares' Pipeline: First And Only Testosterone Auto-Injector

What This Huge George Soros Mistake Can Teach You

George Soros is an investing genius. Still, he does make the occasional mistake. Here is a look at recent mistake with Gilead Sciences Inc. that cost the billionaire serious gains.

Dr. Reddy's (RDY) Generic Xopenex Launched in the US - Analyst Blog

Is It Time to Buy Dividend Stock Teva Pharmaceutical Industries Ltd?

Teva Pharmaceutical shares have buckled under the pressure of generic Copaxone launches. Is the stock now attractively priced?

Teva: On The Auction Block?

OncoGenex's Phase III Prostate Cancer Study Fully Enrolled - Analyst Blog

3 Reasons Dividend Stock Teva Pharmaceutical Industries Ltd. Could Fall

Teva Pharmaceutical Industries has been on a nice bull run for the past year. Here are three reasons why this trend might be about to reverse.

See More TEVA News...

TEVA's Top Competitors

TEVA $53.75 (0.35%)
Current stock: TEVA
JNJ $106.59 (0.05%)
Current stock: JNJ
NVS $94.13 (0.61%)
Current stock: NVS
RHHBY $36.99 (0.24%)
Current stock: RHHBY